PAUL HART: Open Payments
NPI 1295025559 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$207 in 7 payments from 3 companies in 2025. Trend: 2023 $172 · 2024 $0 · 2025 $207
Food & beverage: $207
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 5 | $147 |
| Calliditas Therapeutics US Inc. | 1 | $35 |
| GlaxoSmithKline, LLC. | 1 | $25 |
Products named: TARPEYO, SHINGRIX.
Industry payments across OK — which companies pay providers there.
